Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression
about
Structural analysis of the polo-box domain of human Polo-like kinase 2Mechanisms underlying Plk1 polo-box domain-mediated biological processes and their physiological significance.Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.Dermal wound transcriptomic responses to Infection with Pseudomonas aeruginosa versus Klebsiella pneumoniae in a rabbit ear wound model.SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosisHormonal induction of polo-like kinases (Plks) and impact of Plk2 on cell cycle progression in the rat ovary.Polo-like kinases (plks), a key regulator of cell cycle and new potential target for cancer therapy.Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.From Plk1 to Plk5: functional evolution of polo-like kinasesCombined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.The Polo-like kinase PLKA in Aspergillus nidulans is not essential but plays important roles during vegetative growth and development.Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer TreatmentIdentification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domainRecent Advances and New Strategies in Targeting Plk1 for Anticancer TherapyClinical and molecular characterization of a de novo 19p13.3 microdeletionGenetic mutations associated with metastatic clear cell renal cell carcinoma.Implication of NOTCH1 gene in susceptibility to anxiety and depression among sexual abuse victims.Targeting of polo-like kinases and their cross talk with Aurora kinases--possible therapeutic strategies in human acute myeloid leukemia?Current assessment of polo-like kinases as anti-tumor drug targets.Understanding the Polo Kinase machine.PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis.Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor.Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.p53-Dependent and cell specific epigenetic regulation of the polo-like kinases under oxidative stress.Identification of novel polo-like kinase 1 inhibitors by a hybrid virtual screening.Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up.Mitotic Kinases and p53 Signaling.Proteogenomic characterization and integrative analysis of glioblastoma multiforme.Hippocampal Transcriptomic Profiles: Subfield Vulnerability to Age and Cognitive Impairment.PLK4: a link between centriole biogenesis and cancer.Polo-like kinase 3, hypoxic responses, and tumorigenesis.Plk1 regulates contraction of postmitotic smooth muscle cells and is required for vascular homeostasis.PLK4 is essential for meiotic resumption in mouse oocytes.Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines.The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies.Effects of PLK1 on proliferation, invasion and metastasis of gastric cancer cells through epithelial-mesenchymal transition
P2860
Q27700095-C215BBF5-EF7B-4C78-9B1E-D3FF2B9D64F9Q33574269-033F05EC-FF95-410F-BA62-2C474FFEA398Q33797449-0964A62C-CB90-45E5-8C08-40A1E0E4C52FQ33914024-AC150724-F669-4941-8882-FD7FD3D90DD5Q34328607-53493360-88B3-4FA7-90B5-B8BD65ADD869Q34369091-64D361BC-D2BF-4ADA-BF8A-B280A3DEED3EQ34804703-21D60BFD-A632-4DC6-83A6-590A16ACC32AQ35235743-81F0B055-2D12-48B7-9B54-6A10E7FAE3FAQ35238408-F403BFFC-F56A-4F82-819C-595A830CA479Q35592112-2716BE8F-0D73-4BCB-9C04-0AD7C7C7C24CQ35669467-AC433729-10FC-4038-B13A-6CBFAA12DFF5Q35738986-2C6C9B6F-17D5-4E74-8FA2-3659D4DE134CQ35801683-44912B5C-60B3-478A-A773-C865BB3834CFQ36207913-E3B1931A-7D7C-4A73-80E1-4A6376AA711DQ36386336-750489AA-EA2D-43B0-B2A9-3D0F9BBD79A9Q36942065-15214042-8428-405B-B5F7-391A9E9A0D5CQ37085985-16309064-39BB-4994-BAB6-BEC54CBBE591Q37622634-B1379C0D-5C4C-466D-A365-77399E889233Q37994256-4552096E-68FB-45BA-9905-7423E63364CEQ38211244-71354EC4-A3B5-4E41-84C7-56B92E6739D4Q38331761-2E65F1FF-74A4-436C-933F-538C32C77754Q38712675-B6ED1199-7D18-42D6-9F9A-2C55554EBC22Q38824242-FAC42C2D-5A84-44B7-847C-308DE0210B43Q38872725-E9E6DF25-9098-4BE3-BF2C-017A57329280Q39027006-F3D44987-48EE-4715-BEF4-4F6001E3DBD8Q39348639-255B98A8-8DB5-49FE-96AB-ADA912FC2E24Q41170688-9D9C9320-D498-46BD-BB0E-A728AC8B9B38Q42254103-61F2918A-DE81-4A26-B371-F77B30367E6DQ47099919-73561D7E-3934-43A3-9034-8AF606BA705EQ47251487-F24E1C20-4880-44B0-B99B-1D363A3F3162Q47368506-B7F30ED9-EF08-480B-BFE0-1E965E8C18A0Q47877978-ABE3C7B8-8D77-4402-85C5-8A3A9F17AC28Q48152427-507D08C5-2708-46A8-9706-19066BF20378Q48584046-C0C8CE9C-1A7D-4325-8ABC-478B1A724E11Q50897647-AC838474-31DF-4F3F-99E7-7370A3F0FB55Q51101229-C60964BD-EF81-4872-82C4-ABCE4305CF58Q51763031-46B18C6A-32C6-47E5-BE45-0C21012CA200Q53008515-567D8E1F-7C53-4FC7-8231-49E11359E9F4Q58573014-1A634083-190A-48AC-B1DE-5FAC55EBDA3F
P2860
Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@ast
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@en
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@en-gb
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@nl
type
label
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@ast
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@en
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@en-gb
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@nl
prefLabel
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@ast
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@en
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@en-gb
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Plk5, a polo box domain-only p ...... n and glioblastoma suppression
@en
P2093
Alejandra Ansón
Alonso M Higuero
Beatriz Escobar
Bárbara Meléndez
Gema Pérez
Laura García
P2860
P304
P3181
P356
10.1128/MCB.00607-10
P407
P577
2011-01-18T00:00:00Z